2. Energy-Based Devices · CUTERA

AVICLEAR The first FDA-cleared energy device for mild to severe inflammatory acne

First FDA-cleared energy device for mild to severe inflammatory acne

1726 nm Diode Laser with AviCool™ Contact CoolingOrigin: Cutera Inc. (Brisbane, CA, USA)FDA-Cleared Acne

1726Wavelength

Clinical Philosophy

Elevating patient outcomes with 1726 nm Diode Laser with AviCool™ Contact Cooling.

The first FDA-cleared energy device for the treatment of mild to severe inflammatory acne AviClear’s 1726 nm wavelength treats acne at the source by selectively targeting and suppressing the sebaceous gland safely and effectively.1 Designed with patient comfort in mind, AviClear is enhanced with AviCool™ contact cooling for an optimal and safe treatment experience.

Mechanism of Action: AviClear emits a targeted 1726 nm laser wavelength that is selectively absorbed by lipids within the sebaceous gland. By heating and suppressing sebaceous gland hyperactivity without damaging surrounding epidermal tissue, it reduces sebum production at the root cause of acne breakouts. Integrated AviCool™ continuous contact cooling protects the epidermis and ensures patient comfort during the treatment.

Distributed exclusively across Cambodia through NOVIRA. We empower dermatologists, aesthetic practitioners, and licensed clinics with authentic technology, protocol masterclasses, and dependable after-sales clinical support.

Special Features

Three pillars behind AVICLEAR.

Rigorous scientific evidence, targeted clinical efficacy, and certified safety.

Innovative Technology

Energy Modality1726 nm Diode Laser with AviCool™ Contact Cooling
Optical Parameters1726 nm
Core CharacteristicThe first FDA-cleared energy device for mild to severe inflammatory acne

Clinical Indications

Target Indication 01Mild, Moderate, and Severe Inflammatory Acne Vulgaris
Target Indication 02Excess Sebaceous Gland Secretion & Oily Skin
Target Indication 03Refractory or Treatment-Resistant Acne

Certified Standard

Regulatory StatusFDA-Cleared Acne
Origin & AuthenticityManufactured in Cutera Inc. (Brisbane, CA, USA). Sourced directly from primary laboratory.
B2B DistributionRestricted strictly to licensed aesthetic physicians, certified dermatologists, and clinical centers.

SAY GOODBYE

TO IMPERFECTIONS

Documented clinical transformations achieved with our medical aesthetic platforms and biostimulator formulations. Drag the slider to reveal clinical outcomes.